
Overview
Jose E. Sarriera, MD, serves as a medical oncologist/ hematologist at Orlando Health Cancer Institute. Dr. Sarriera is board-certified in medical oncology and hematology and is the section leader for myeloma, lymphoma and leukemia cancers.He received his medical degree from the University of Puerto Rico School of Medicine. He completed an internship in internal medicine at Washington University School of Medicine in St. Louis, where he also completed his residency in internal medicine. Dr. Sarriera fulfilled a medical oncology/hematology fellowship at The University of Texas MD Anderson Cancer Center in Houston.Dr. Sarriera has published several articles in peer-reviewed journals and has a published book chapter on urologic complications. He has received several honors and awards, including the University of Puerto Rico Academic Scholarship Award. He is also involved in several Orlando Health committees, including being a member of the Blood Bank Committee and chairman of the Hematology and Oncology Subcommittee.Dr. Sarriera is a member of the American Society of Hematology and the American Society of Clinical Oncology.
Dr. Sarriera is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration.
Dr. Sarriera is board certified in American Board Of Internal Med. - Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine - Hematology. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 S. Orange Ave., Orlando, FL 32806
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Orlando Health Cancer Institute - Downtown Orlando
Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Florida Cancer Specialists & Research Institute, LLC
Sonalee Shroff is a Hematologist and an Oncologist practicing medicine in Winter Park, Florida. Dr. Shroff is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Shroff is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Jose E. Sarriera
How do I make an appointment with Dr. Jose E. Sarriera?
You can book an appointment with Dr. Jose E. Sarriera by calling their office at 321-841-1869. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jose E. Sarriera a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jose E. Sarriera is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jose E. Sarriera specialize in?
While Dr. Jose E. Sarriera is a Hematology, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Follicular Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Jose E. Sarriera participate in research or clinical trials?
Yes. Dr. Jose E. Sarriera has published 2 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Dr. Jose E. Sarriera's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jose E. Sarriera accept my insurance?
Dr. Jose E. Sarriera accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 321-841-1869 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Sarriera isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Sarriera isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Sarriera isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Sarriera isDistinguished. Learn about Follicular Lymphoma.
- IgG4-Related DiseaseDr. Sarriera isDistinguished. Learn about IgG4-Related Disease.
- Large-Cell Immunoblastic LymphomaDr. Sarriera isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Sarriera isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaDr. Sarriera isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Sarriera isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Sarriera isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Sarriera isAdvanced. Learn about Angiosarcoma.
- B-Cell LymphomaDr. Sarriera isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Acute Mountain SicknessDr. Sarriera isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Sarriera isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Sarriera isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaDr. Sarriera isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Sarriera isExperienced. Learn about Agranulocytosis.

